Cover Image

The possible critical role of T-cell help in DSA-mediated graft loss

In this review, we discuss a possible central role of T-cell help in severe forms of graft damage mediated by donor-specific HLA antibodies (DSA). Some kidney transplant recipients with pretransplant DSA show a high graft failure rate, whereas in other patients DSA do not harm the transplanted kidne...

Full description

Saved in:
Bibliographic Details
Main Authors: Süsal, Caner (Author) , Pham, Lien (Author) , Zeier, Martin (Author) , Morath, Christian (Author)
Format: Article (Journal)
Language:English
Published: 06 February 2018
In: Transplant international
Year: 2018, Volume: 31, Issue: 6, Pages: 577-584
ISSN:1432-2277
DOI:10.1111/tri.13126
Online Access:Verlag, Volltext: https://doi.org/10.1111/tri.13126
Verlag, Volltext: https://onlinelibrary.wiley.com/doi/abs/10.1111/tri.13126
Get full text
Author Notes:Caner Süsal, Antonij Slavcev, Lien Pham, Martin Zeier, Christian Morath
Description
Summary:In this review, we discuss a possible central role of T-cell help in severe forms of graft damage mediated by donor-specific HLA antibodies (DSA). Some kidney transplant recipients with pretransplant DSA show a high graft failure rate, whereas in other patients DSA do not harm the transplanted kidney and in most cases, disappear shortly after transplantation. Analyzing 80 desensitized highly immunized kidney transplant recipients and another multicenter cohort of 385 patients with pretransplant HLA antibodies, we reported recently that an ongoing T-cell help from an activated immune system, as measured by an increased level of soluble CD30 in serum, might be necessary for the DSA to exert a deleterious effect. Patients positive for both pretransplant DSA and sCD30 appear to require special measures, such as the elimination of DSA from the circulation, potent immunosuppression, good HLA-matching, and intense post-transplant monitoring, whereas exclusion of DSA-positive patients from transplantation in the absence of high sCD30 may not be justified in all cases, even if the pretransplant DSA are strong and complement-activating.
Item Description:Gesehen am 25.04.2019
Physical Description:Online Resource
ISSN:1432-2277
DOI:10.1111/tri.13126

Similar Items